Private Trust CO Na Arcutis Biotherapeutics, Inc. Transaction History

Private Trust CO Na

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 28, 2023	BUY	$7.51 - $15.0 $187 - $375	25 Added 13.16%	215 $2,000
Q1 2023 Apr 12, 2023	BUY	$10.23 - $17.14 $306 - $514	30 Added 18.75%	190 $2,000
Q4 2022 Jan 18, 2023	BUY	$13.96 - $20.4 $698 - $1,019	50 Added 45.45%	160 $0
Q3 2022 Oct 17, 2022	BUY	$17.85 - $26.95 $803 - $1,212	45 Added 69.23%	110 $2,000
Q2 2022 Sep 16, 2022	BUY	$16.33 - $22.2 $1,061 - $1,443	65 New	65 $1,000

172

126M

498K

1.64M

Ticker ARQT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,187,500
Market Cap $631M
Description
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...

Get notified when there are updates to the investment portfolio of Private Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Private Trust CO Na with notifications on news.